Clinical trials
Completed Phase 2/3 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
301 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 7 |
| 2002 | 7 |
| 2003 | 11 |
| 2004 | 17 |
| 2005 | 20 |
| 2006 | 15 |
| 2007 | 12 |
| 2008 | 17 |
| 2009 | 14 |
| 2010 | 15 |
| 2011 | 13 |
| 2012 | 14 |
| 2013 | 11 |
| 2014 | 15 |
| 2015 | 17 |
| 2016 | 13 |
| 2017 | 9 |
| 2018 | 21 |
| 2019 | 8 |
| 2020 | 11 |
| 2021 | 11 |
| 2022 | 8 |
| 2023 | 5 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 301 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Alberta | 16 |
| University Health Network, Toronto | 12 |
| University of British Columbia | 10 |
| Pfizer | 9 |
| AstraZeneca | 8 |
| Ottawa Hospital Research Institute | 7 |
| University of Manitoba | 7 |
| Ottawa Heart Institute Research Corporation | 6 |
| Baxalta now part of Shire | 5 |
| Bristol-Myers Squibb | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 8 |
| Diabetes Mellitus, Type 2 | 7 |
| Hemophilia A | 7 |
| Alzheimer Disease | 6 |
| HIV Infections | 6 |
| Breast Neoplasms | 5 |
| Hyperlipidemias | 5 |
| Major Depressive Disorder | 5 |
| Neoplasm Metastasis | 5 |
| Prostatic Neoplasms | 5 |
Trials
Showing 1 to 25 of 301. Each trial links to its page on Pharma Observatory.
201 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.